Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 8.51% is 53% below its 5-year average of 18.22%, near the low end of its 5-year range (8.51%–34.86%).
As of the fiscal period ended Wednesday, December 31, 2025. 12.27% below its 12-month average of 9.70%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
8.51%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
9.70%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
12.91%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
18.22%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
16.77%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
14.91%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
8.20%
CURRENT VS TTM AVG
-12.27%
CURRENT VS 3Y AVG
-34.09%
CURRENT VS 5Y AVG
-53.29%
CURRENT VS 10Y AVG
-49.24%
CURRENT VS 15Y AVG
-42.91%
CURRENT VS 20Y AVG
+3.79%
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-0.23%
vs the sector median at left
Regeneron Pharmaceuticals, Inc.
Market Cap
$67.58B
Return on Invested Capital (ROIC)
8.51%
TTM Avg
9.70%
3Y Avg
12.91%
5Y Avg
18.22%
Market Cap
$65.77B
Return on Invested Capital (ROIC)
8.78%
TTM Avg
7.46%
3Y Avg
6.12%
5Y Avg
5.55%
Market Cap
$60.29B
Return on Invested Capital (ROIC)
13.23%
TTM Avg
15.09%
3Y Avg
14.58%
5Y Avg
13.58%
Market Cap
$76.60B
Return on Invested Capital (ROIC)
7.35%
TTM Avg
7.02%
3Y Avg
7.07%
5Y Avg
6.50%
Market Cap
$56.65B
Return on Invested Capital (ROIC)
4.73%
TTM Avg
4.38%
3Y Avg
4.32%
5Y Avg
3.88%
Market Cap
$53.41B
Return on Invested Capital (ROIC)
11.37%
TTM Avg
10.09%
3Y Avg
4.86%
5Y Avg
-0.22%
Market Cap
$81.91B
Return on Invested Capital (ROIC)
6.65%
TTM Avg
6.70%
3Y Avg
7.11%
5Y Avg
7.33%
Market Cap
$84.78B
Return on Invested Capital (ROIC)
18.53%
TTM Avg
17.61%
3Y Avg
17.07%
5Y Avg
16.89%
Market Cap
$47.58B
Return on Invested Capital (ROIC)
11.40%
TTM Avg
11.07%
3Y Avg
14.43%
5Y Avg
15.83%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. (REGN) | $67.58B | 8.51% | 9.70% | 12.91% | 18.22% |
| Boston Scientific Corporation (BSX)vs › | $65.77B | 8.78% | 7.46% | 6.12% | 5.55% |
| Cencora, Inc. (COR)vs › | $60.29B | 13.23% | 15.09% | 14.58% | 13.58% |
| Cigna Corporation (CI)vs › | $76.60B | 7.35% | 7.02% | 7.07% | 6.50% |
| Becton, Dickinson and Company (BDX)vs › | $56.65B | 4.73% | 4.38% | 4.32% | 3.88% |
| Cardinal Health, Inc. (CAH)vs › | $53.41B | 11.37% | 10.09% | 4.86% | -0.22% |
| Elevance Health Inc. (ELV)vs › | $81.91B | 6.65% | 6.70% | 7.11% | 7.33% |
| HCA Healthcare, Inc. (HCA)vs › | $84.78B | 18.53% | 17.61% | 17.07% | 16.89% |
| Edwards Lifesciences Corporation (EW)vs › | $47.58B | 11.40% | 11.07% | 14.43% | 15.83% |
| Humana Inc. (HUM)vs › | $46.74B | 3.12% | 3.25% | 5.37% | 7.01% |
ROIC
8.5%
ROE
14.1%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 8.51% |
| 2024-12-31 | 10.89% |
| 2023-12-31 | 13.81% |
| 2022-12-31 | 18.44% |
| 2021-12-31 | 34.86% |
| 2020-12-31 | 22.80% |
| 2019-12-31 | 15.15% |
| 2018-12-31 | 20.55% |
| 2017-12-31 | 13.49% |
| 2016-12-31 | 13.59% |
| 2015-12-31 | 12.34% |
| 2014-12-31 | 10.25% |
| 2013-12-31 | 14.22% |
| 2012-12-31 | 19.74% |
| 2011-12-31 | -14.33% |
| 2010-12-31 | -7.26% |
| 2009-12-31 | -10.79% |
| 2008-12-31 | -14.02% |
| 2007-12-31 | -9.16% |
| 2006-12-31 | -15.10% |
| 2005-12-31 | 14.20% |
| 2004-12-31 | 1.29% |
| 2003-12-31 | -23.78% |
| 2002-12-31 | -32.52% |
| 2001-12-31 | -12.76% |
| 2000-12-31 | -12.96% |
| 1999-12-31 | -17.61% |
| 1998-12-31 | 0.21% |
| 1997-12-31 | -4.70% |
| 1996-12-31 | -13.39% |
